Group 1 - KKR has received unconditional approval from the Wuhan Market Supervision Administration for its acquisition of a stake in Envision International Limited, which is speculated to be related to Dayao Beverage Co., Ltd. [1] - Dayao Beverage's response to the acquisition speculation has shifted from denial to a vague "no comment," indicating potential developments in the future [1] - KKR, known as the "King of Wall Street Acquisitions," has a total asset management scale of $664 billion as of Q1 2025 and has previously made successful investments in consumer companies [4] Group 2 - Dayao Beverage is a leading soda brand in Northern China, with 78.4% of consumers purchasing it from restaurants and 55.9% from convenience stores [4] - The company has established seven production bases, with a total investment of 1.26 billion yuan in its production line in Shaanxi, which has an annual capacity of 500,000 tons [4] - Dayao Beverage is reportedly preparing for an IPO in Hong Kong by the second half of 2025, aiming to raise up to $500 million, although the company has stated it is currently focused on operational development [5]

Core Points - Walgreens Boots Alliance shareholders approved Sycamore Partners' $10 billion buyout offer, with the deal expected to close in the third or fourth quarter of 2025, pending regulatory approvals [2][5] - The buyout offer is priced at $11.45 per share, representing a 29% premium over Walgreens' stock price in December [3] - Approximately 96% of votes cast during the special shareholder meeting were in favor of the merger [4] Company Strategy - The CEO of Walgreens expressed appreciation for shareholder support, indicating that the partnership with Sycamore will help accelerate the company's turnaround strategy and improve customer and employee experiences [5] - Walgreens has faced challenges in recent years, including a failed in-store clinic rollout that resulted in store closures and significant financial losses [6] Financial Performance - Walgreens invested over $6 billion in VillageMD to gain a controlling stake, but has since scaled back on clinic expansions due to difficulties in filling patient panels, contributing to a net loss of over $8 billion for fiscal 2024 [7]

Group 1 - KKR, a US private equity firm, is reportedly planning to acquire an 85% stake in a Chinese beverage company, speculated to be Daya Beverage [1] - The transaction has been in discussion for about a year according to sources close to the deal [1] - Daya Beverage is projected to generate revenue in the range of several billion yuan in 2024 [1] Group 2 - Daya Beverage is preparing for a potential IPO in Hong Kong, expected to take place as early as the second half of 2025 [1] - KKR is recognized as a leading private equity firm with a reputation for being cautious and not overly promotional in its investment approach [1] - KKR is one of the oldest and most experienced private equity investment firms globally [1]